3.8 Article

Dietary patterns in non-alcoholic fatty liver disease (NAFLD): Stay on the straight and narrow path!

Journal

CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS
Volume 34, Issue -, Pages S24-S31

Publisher

ELSEVIER
DOI: 10.1016/j.arteri.2021.10.001

Keywords

Non-alcoholic fatty liver disease; Mediterranean diet; Dietary Approaches to Stop Hypertension diet; Vegetarian diet; Ketogenic diet; Intermittent fasting; Paleo diet

Funding

  1. Amgen
  2. Astra Zeneca
  3. Boehringer Ingelheim
  4. Kowa
  5. Eli Lilly
  6. Meda
  7. Mylan
  8. Merck Sharp Dohme
  9. Novo Nordisk
  10. Novartis
  11. Roche Diagnostics
  12. Sanofi
  13. Servier

Ask authors/readers for more resources

Non-alcoholic fatty liver disease (NAFLD) is the most frequent hepatic disease globally. Lifestyle interventions, particularly the Mediterranean diet, are recommended for prevention and treatment of NAFLD due to the lack of official drug therapy options.
Non-alcoholic fatty liver disease (NAFLD) is the most frequent hepatic disease globally. NAFLD patients are at an increased risk of both liver and cardiovascular morbidity and mortality, as well as all-cause death. NAFLD prevalence is rapidly increasing worldwide and, thus, there is an urgent need for health policies to tackle its development and complications. Currently, since there is no drug therapy officially indicated for this disease, lifestyle interventions remain the first-line therapeutic option. In the present narrative review, we discuss the effects of certain dietary patterns on NAFLD incidence and progression. The Mediterranean diet is regarded as the diet of choice for the prevention/treatment of NAFLD and its complications, based on the available evidence. Other plant-based dietary patterns (poor in saturated fat, refined carbohydrates, red and processed meats) are also beneficial [i.e., Dietary Approaches to Stop Hypertension (DASH) and vegetarian/vegan diets], whereas more data are needed to establish the role of ketogenic, intermittent fasting and paleo diets in NAFLD. Nevertheless, there is no ``one-size-fits-all'' dietary intervention for NAFLD management. Clinicians should discuss with their patients and define the diet that each individual prefers and is able to implement in his/her daily life. (C) 2021 Sociedad Espanola de Arteriosclerosis. Published by Elsevier Espana, S.L.U. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available